Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Study Design 10 Considerations for Osteoarthritis Study Assessments By Scott Millard October 12, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 9: Training Achieves Smaller Placebo Responses By Scott Millard October 10, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 8: Finding Another Way By Scott Millard October 3, 2017 Clinical ResearchPhase 1 - Phase 4 The ABC’s of OA By Scott Millard September 26, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 7: Drug-Placebo Interactions By Scott Millard September 21, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 6: Measuring the Placebo Response By Scott Millard September 13, 2017 Previous 1 2 3 4 5 6 Next × ALSO OF INTERESTPremier Voices #3: The Placebo Problem Part 1...Operationalizing Fibromyalgia TrialsLeveraging Real-World Data & Real-World...